| 000 | 01722 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516170358.0 | ||
| 264 | 0 | _c20140619 | |
| 008 | 201406s 0 0 eng d | ||
| 022 | _a1536-4844 | ||
| 024 | 7 |
_a10.1097/MIB.0b013e3182a77b41 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPaul, Stephane | |
| 245 | 0 | 0 |
_aTherapeutic drug monitoring of infliximab and mucosal healing in inflammatory bowel disease: a prospective study. _h[electronic resource] |
| 260 |
_bInflammatory bowel diseases _cNov 2013 |
||
| 300 |
_a2568-76 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Observational Study | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 |
_aBiomarkers _xanalysis |
| 650 | 0 | 4 |
_aColitis, Ulcerative _xdrug therapy |
| 650 | 0 | 4 |
_aCrohn Disease _xdrug therapy |
| 650 | 0 | 4 | _aCross-Sectional Studies |
| 650 | 0 | 4 | _aDrug Monitoring |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aGastrointestinal Agents _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfliximab |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMucous Membrane _xdrug effects |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 |
_aWound Healing _xdrug effects |
| 700 | 1 | _aDel Tedesco, Emilie | |
| 700 | 1 | _aMarotte, Hubert | |
| 700 | 1 | _aRinaudo-Gaujous, Melanie | |
| 700 | 1 | _aMoreau, Amelie | |
| 700 | 1 | _aPhelip, Jean-Marc | |
| 700 | 1 | _aGenin, Christian | |
| 700 | 1 | _aPeyrin-Biroulet, Laurent | |
| 700 | 1 | _aRoblin, Xavier | |
| 773 | 0 |
_tInflammatory bowel diseases _gvol. 19 _gno. 12 _gp. 2568-76 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/MIB.0b013e3182a77b41 _zAvailable from publisher's website |
| 999 |
_c23067857 _d23067857 |
||